Published in Eur Arch Otorhinolaryngol on February 15, 2014
Salvage surgery for head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2014) 0.77
Transoral laser microsurgery for T1b glottic cancer: review of 51 cases. Eur Arch Otorhinolaryngol (2016) 0.75
Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches. JAMA Otolaryngol Head Neck Surg (2013) 1.14
Proposal for a rational classification of neck dissections. Head Neck (2010) 1.04
Surgical treatment of lung metastases of head and neck tumors. Am J Surg (1997) 0.91
Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx. Head Neck (1997) 0.90
Supracricoid partial laryngectomy as salvage surgery after radiation failure. Head Neck (2002) 0.87
CyberKnife stereotactic radiosurgery for recurrent squamous cell carcinoma of the head and neck following salvage surgery with close or positive margins. Laryngoscope (2010) 0.84
Vascularized free tissue transfer for reconstruction of ablative defects in oral and oropharyngeal cancer patients undergoing salvage surgery following concomitant chemoradiation. Int J Oral Maxillofac Surg (2012) 0.84
The role of salvage surgery in organ preservation strategies in advanced head and neck cancer. B-ENT (2008) 0.82
RADICAL WERTHEIM AS A SALVAGE PROCEDURE. PATIENTS WITH RECURRENCE FOLLOWING INITIAL DEFINITIVE RADIOTHERAPY. Am J Obstet Gynecol (1965) 0.81
Stomal recurrence: pathophysiology, treatment and prevention. Acta Otolaryngol (2003) 0.80
Total laryngectomy for salvage in cancers of the glottic region. Laryngoscope (1975) 0.80
[Effects of tumor localization in the prognosis of salvage laryngectomies]. Ann Otolaryngol Chir Cervicofac (1971) 0.79
The role of elective neck dissection during salvage surgery in head and neck squamous cell carcinoma. Acta Otolaryngol (2013) 0.79
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid (2012) 2.71
The future of the TNM staging system in laryngeal cancer: time for a debate? Eur Arch Otorhinolaryngol (2008) 2.58
Paragangliomas of the head and neck. Oral Oncol (2004) 2.47
Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol (2006) 2.40
Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope (2014) 2.21
Analysis of pneumatization and neurovascular structures of the sphenoid sinus using cone-beam tomography (CBT). Acta Radiol (2012) 2.19
Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg (2002) 2.08
Primary mucosal malignant melanoma of the head and neck. Head Neck (2002) 2.07
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid (2014) 2.04
Micromedullary thyroid cancer: how micro is truly micro? Ann Surg Oncol (2009) 1.99
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol (2006) 1.97
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res (2010) 1.97
Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer (2003) 1.94
Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One (2010) 1.94
Neuroendocrine neoplasms of the larynx: an overview. Head Neck (2009) 1.92
Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2011) 1.80
Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg (2003) 1.74
Management of well-differentiated thyroid carcinoma presenting within a thyroglossal duct cyst. J Surg Oncol (2002) 1.73
Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer (2011) 1.71
Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol (2006) 1.70
Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. PLoS One (2009) 1.69
Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med (2007) 1.69
Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg (2008) 1.68
Poorly differentiated and anaplastic thyroid cancer. Cancer Control (2006) 1.66
Analysis of prognostic factors in 146 patients with anterior skull base sarcoma: an international collaborative study. Cancer (2007) 1.63
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience. Int J Radiat Oncol Biol Phys (2009) 1.58
Thyroglossal duct cyst: personal experience and literature review. Auris Nasus Larynx (2007) 1.57
Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol (2012) 1.55
Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. Int J Cancer (2008) 1.51
Parapharyngeal lymph node metastasis: an unusual presentation of papillary thyroid carcinoma. Head Neck (2004) 1.48
Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol (2010) 1.48
Sinonasal tumors: a clinicopathologic update of selected tumors. Eur Arch Otorhinolaryngol (2012) 1.43
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer. Cancer J (2006) 1.42
Effectiveness of radiochemotherapy on lymph node metastases in patients with stage IV oropharyngeal cancer. Oral Oncol (2004) 1.42
An outline of the history of head and neck oncology. Oral Oncol (2007) 1.42
Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck? J Am Coll Surg (2005) 1.39
Update on hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol (2008) 1.39
Complications of craniofacial resection for malignant tumors of the skull base: report of an International Collaborative Study. Head Neck (2005) 1.39
Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncol (2002) 1.38
FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol (2006) 1.37
Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res (2007) 1.37
Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia. Clin Cancer Res (2009) 1.37
Aspergillosis--and a misleading sensitivity result. Lancet (2007) 1.36
Pathogenesis of lymphangiomas. Virchows Arch (2008) 1.35
Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck (2010) 1.34
Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck (2010) 1.34
Advances and applications of oral cancer basic research. Oral Oncol (2011) 1.33
Craniofacial resection for malignant paranasal sinus tumors: Report of an International Collaborative Study. Head Neck (2005) 1.31
Management of sarcomas of the head and neck in adults. Oral Oncol (2003) 1.31
Evidence-based review of treatment options for patients with glottic cancer. Head Neck (2011) 1.30
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer (2009) 1.30
Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol (2009) 1.29